MAPT and Alzheimer disease: Pharmacological inhibition of OGA stimulates autophagy in two AD models, the JNPL3 tauopathy mouse model and the 3 × Tg-AD mouse model, preventing the accumulation of AD-related toxic species such as Tau (Zhu et al., 2018).